期刊文献+

化疗药在动脉化疗栓塞治疗大鼠肝癌实验中的价值 被引量:1

The Value of Chemotherapy Drug in Transarterial Chemoembolization Treating Hepatic Carcinoma of Experimental Rat
下载PDF
导出
摘要 目的 评价经肝动脉化疗栓塞术(transarterial chemoembolization,TACE)治疗大鼠移植性肝癌中化疗药物的 抑瘤及肝损害作用。材料与方法 复制大鼠移植性肝癌模型,经肝动脉插管采取以下介入治疗方案:A组(小剂 量TACE,n=10):经肝动脉灌注丝裂霉素(MMC)50μg+超液态碘油(UFLP)50μl+明胶海绵粉(GF)25 μg;B组 (常规剂量TACE,n=10)经肝动脉灌注5-FU 5 mg+MMC 50μg+UFLP 50μl+GF 25 μg;C组(对照组,n=10)经肝 动脉灌注生理盐水0.3 ml,介入术前及术后12 d,分别行MRI检查测量肿瘤体积V1及V2,并计算、比较V2/V1,取 术后肿瘤及瘤周肝组织行病理学检查,并行肝功能检查。结果 存活27只大鼠,V2/V1比较结果:C组高于A、B 组,且均有显著性差异(P<0.05),而A、B两组无显著性差异(P>0.05);三组间肿瘤坏死程度分别为58.25%、 55.60%、26.67%,C组低于A、B组,均存在显著性差异(P<0.05),而A、B两组无显著性差异(P>0.05);三组间瘤 周肝组织改变分别为肝细胞胞浆疏松化、气球样变、无变性坏死;肝功能比较结果:A组谷丙转氨酶(ALT)、谷草转 氨酶(AST)水平高于C组(P<0.05),而B组又高于A组(P<0.05),A、C组间总胆红素(1TBIL)与白蛋白(ALB)水平 无显著性差异(P>0.05),但前者低于B组(P<0.05)后者高于B组(P<0.05)。结论 一定剂量化疗药的TACE 可有效治疗大鼠移植性肝肿瘤,增加化疗药剂量并不能增加这种作用,相反能明显加重对肝组织的损害及对肝功 能的影响作用。 Objective To evaluate the inhibiting effect of tumor growth and damage to liver by chemotherapy drug in transarterial chemoembolization (TACE) treating rat hepatic carcinoma. Materials and Methods Hepatic carcinoma models were made in Wistar rats, and then the following protocols of interventional therapy were carried out by TACE : group A (low dosage group, n = 10) mitomycin50μg+ ultrafluid lipiodol 50μl + gelfoam spong powder25 ug; group B (conventional dosage group, n = 10) 5 - FU 5mg + mitomycin 50μg + ultrafluid lipiodol 50μl + gelfoam spong powder 25μg; group C (general control group, n = 10) 0.9% NaCl 0.3 ml. TACE before and 12 days later, MRI were performed respectively to determine the tumor volume V1, V2 and V2/V1. All tumors tissue and pericancer liver tissues were performed with pathological examination. Liver function of every rat was assayed. Results In 27 survival rats, the values of V2/V1 were existed significant differences between group A and C, B and C ( P 〈 0.05), not between A and B; the extent of necrosis of tumors were 58.25% , 55.60% , 26.67% , in group A, B, C respectively, significant differences were observed between the group A and C, B and C ( P 〈 0.05), not between A and B ( P 〉 0.05) ; Hydropic degeneration was showed in the group A and B, characterized by loose shape and balloon shape respectively, not in group C ; The values of ALT and AST in group B were higher than those in the group A and C ( P 〈 0.05 ), also these higher in the group B than that in the group C ( P 〈 0.05) ; significant differences were not found in the values of TBIL and ALB between the group A and C (P 〉 0.05), but TBIL in the two group lower than that in group B, ALB were higher than that in the group B ( P 〈 0.05). Conclusion TACE with certain dosage chemotherapy drug can effectively treat implantation hepatic carcinoma of rat, increased dosage of chemotherapy drug cannot increase the therapeutic effect, on the other hand, enhance the damage to liver parenchyma and the influence on liver function.
出处 《临床放射学杂志》 CSCD 北大核心 2005年第11期1012-1016,共5页 Journal of Clinical Radiology
关键词 化疗药 经肝动脉化疗栓塞 治疗 肝损害 Anticancer Drug Transarterial chemoembolization Therapy Liver damage
  • 相关文献

参考文献14

二级参考文献49

共引文献113

同被引文献12

  • 1陈晓明,罗鹏飞,林华欢,周泽健,邵培坚,符力,李伟科.经导管肝动脉化疗栓塞联合经皮无水乙醇注射治疗肝癌的长期疗效观察[J].癌症,2004,23(7):829-832. 被引量:29
  • 2胡道予,李震,王南,张玉琴,黄艳蓉.小剂量与常规剂量化疗药物经动脉化疗栓塞术治疗肝癌的对照研究[J].临床放射学杂志,2004,23(6):502-506. 被引量:24
  • 3Lu W,Li Y,He X,et al.Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis:evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.Hepatogastroenterology,2003,50:2079
  • 4Bartolozzi C,Lencioni R,Caramella D,et al.Treatment of large HCC:transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.Radiology.1995,197:812
  • 5Lencioni R,Paolicchi A,Moretti M,et al.Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma:local therapeutic effect and long-term survival rate.Eur Radiol,1998,8:439
  • 6Allgaier HP,Deibert P,Olschewski M,et al.Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.Int J Cancer,1998,79:601
  • 7Greten TF,Papendorf F,Bleck JS,et al.Survival rate in patients with hepatocellular carcinoma:a retrospective analysis of 389 patients.Br J Cancer,2005,92:1862
  • 8Koda M,Murawaki Y,Mitsuda A,et al.Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma:a randomized control study.Cancer,2001,92:1516
  • 9Li YH,Wang CS,Liao LY,et al.Long-term survival of Taiwan Residents patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection.J Formos Med Assoc,2003,102:141
  • 10陈晓明,罗鹏飞.经皮乙醇注射治疗肝癌的现状[J].国外医学(肿瘤学分册),1998,25(3):173-175. 被引量:8

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部